Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00572195 · ClinicalTrials.gov registry record · Phase 4
RNS® System LTT Study
A Phase 4 study, sponsored by NeuroPace.
- Completed
- Registry status
- Phase 4
- Development phase
- 230
- Enrollment target
NCT00572195 is a Phase 4 study that has completed, run by NeuroPace. The registered enrollment target is 230 participants.
The verdict
NCT00572195, a Phase 4 study, has completed, sponsored by NeuroPace.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 230 participants
- Enrollment target
Study Summary
The RNS® System LTT study is designed to assess the ongoing safety and to evaluate the long-term efficacy of the RNS® System as an adjunctive therapy in reducing the frequency of seizures in individuals 18 years of age or older with partial onset seizures that are refractory to two or more antiepileptic medications. Candidates will continue to receive their epilepsy medications while participating in the trial.
Interventions
- DEVICE RNS® System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2006-04 |
| Est. Completion | 2018-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00572195
The ClinicalTrials.gov registry entry for NCT00572195 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 230 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NeuroPace, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RNS® System is the first listed.
NCT00572195 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00572195 about?
NCT00572195 is a clinical study titled "RNS® System LTT Study". The RNS® System LTT study is designed to assess the ongoing safety and to evaluate the long-term efficacy of the RNS® System as an adjunctive therapy in reducing the frequency of seizures in individuals 18 years of age or older with partial onset seizures that are refractory to two or more antiepile...
What is the current status of trial NCT00572195?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 230 participants. The study started on 2006-04. Estimated completion is 2018-05.
What interventions are being tested in trial NCT00572195?
The interventions under investigation include: RNS® System (DEVICE).
Who is sponsoring clinical trial NCT00572195?
This trial is sponsored by NeuroPace, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.